v3.25.1
Condensed Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 16,310 $ 20,245
Restricted cash 300 386
Accounts receivable, net of allowance for credit losses of $811 and $653, respectively 16,525 12,136
Inventory 11,813 10,523
Prepaid expenses and other current assets 3,467 2,823
Total current assets 48,415 46,113
Property and equipment, net 99 102
Right of use assets, net 109 138
Intangible assets, net 1,049 975
Other assets 1,725 2,187
Total assets 51,397 49,515
Current liabilities:    
Accounts payable 12,708 11,281
Accrued and other expenses 16,478 16,378
Current portion of deferred revenues 1,457 1,404
Line of credit 8,498 6,263
Current portion of long-term and other debt 1,554 1,103
Total current liabilities 40,695 36,429
Long-term debt, net 3,846 4,331
Common stock warrant liabilities 18,656 25,343
Other long-term liabilities 200 226
Total liabilities 63,397 66,329
Commitments and Contingencies
Mezzanine equity:    
Mezzanine equity 13,806 12,937
Stockholders’ deficit:    
Common stock, $0.0001 par value, 107,142,857 shares authorized as of March 31, 2025 and December 31, 2024; 15,808,849 and 15,725,783 shares issued and outstanding as of March 31, 2025 and December 31, 2024, respectively 2 2
Additional paid-in capital 239,362 238,442
Accumulated deficit (265,170) (268,195)
Total stockholders’ deficit (25,806) (29,751)
Total liabilities, mezzanine equity, and stockholders' deficit 51,397 49,515
Series A Convertible Preferred Stock    
Mezzanine equity:    
Mezzanine equity 5,651 5,151
Series B Convertible Preferred Stock    
Mezzanine equity:    
Mezzanine equity 3,800 3,452
Redeemable Common Stock    
Mezzanine equity:    
Mezzanine equity $ 4,355 $ 4,334